红日药业：12月12日召开董事会会议

Company Overview - Hongri Pharmaceutical (SZ 300026) announced its ninth board meeting on December 12, 2025, in Tianjin, discussing the amendment of the company's articles of association [1] Revenue Composition - For the year 2024, the revenue composition of Hongri Pharmaceutical is as follows: - Traditional Chinese medicine formula granules and decoction pieces account for 46.15% - Finished drugs account for 24.72% - Medical devices account for 19.39% - Auxiliary materials and raw materials account for 8.33% - Other industries account for 1.42% [1] Market Capitalization - As of the report, Hongri Pharmaceutical has a market capitalization of 10.9 billion yuan [1]